phase readout
saveNCT07193420: Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies
NOT_YET_RECRUITINGupdated 29d ago
community read0 votes
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: GVHD - Graft-Versus-Host Disease, HSCT, Haploidentical Stem Cell Transplantation
view source ↗
comments(0)
5-min edit window · permanent after that